胎盘植入产后大出血介入治疗临床分析  

The Clinical Analysis of Placenta Accreta Postpartum Hemorrhage with Interventional Therapy

作　　者：邹晓琴[1] 吴熙中[1] 张夏兰[1] 黄友琼[1] 李丹妍[1] 

机构地区：[1]汕头大学医学院第二附属医院妇产科,广东汕头515000

出　　处：《河北医学》2011年第3期343-345,共3页Hebei Medicine

摘　　要：目的:探讨植入性胎盘产后大出血行介入治疗的有效性及安全性。方法:回顾2003年6月至2010年5月在我院进行介入(子宫动脉灌注甲氨蝶呤+栓塞)方法治疗胎盘植入并产后大出血的患者共13例,对其治疗效果、预后及不良反应进行分析。结果:13例患者有12例止血成功,并且保留了子宫,仅1例患者术后行子宫切除,治疗成功率92.3%,术后患者不良反应轻微,患者血HCG、性激素及月经周期于3-8个月内均恢复正常,4例再次妊娠足月顺产。结论:应用介入方法治疗胎盘植入产后大出血,疗效显著,成功率高,能最大限度的保留子宫及生育功能,且不良反应小,是首选的治疗方法。Objective： To investigate the effectiveness and safety about interventional therapy for postpartum hemorrhage of placenta accreta.Method： Analysis the treatment,prognosis and adverse reactions for 13 cases,which were diagnosed postpartum hemorrhage of placenta accreta and were used uterine arterial infusion of methotrexate combined with embolization in our hospital from June 2003 to May 2010.Result： In 13 patients,12 cases were successful hemostasis and retained the uterus with the success rate of 92.3%,only 1 patient with postoperative hysterectomy.In patients after surgery the adverse reactions were mild,and the blood HCG,hormones and menstrual cycle in 3 to 8 months became normal.4 patients had pregnancy and were natural labor again.Conclusion： The intervention treatment for placenta accreta postpartum hemorrhage is the prefered therapeutic method,because of significantly curative effect,high success rate,maximatily of the retention of uterus and fertility and little side effects.

关 键 词：胎盘植入 介入治疗 产后大出血 甲氨蝶呤 

分 类 号：R714.462[医药卫生—妇产科学]